Mazzacco Catherine reported KRYS

Source

Document

SEC Form 4

Publisher

U.S. Securities and Exchange Commission (EDGAR)

Document ID

0001967722-26-000002

Machine-readable

Structured copy

Timestamps

Event (reported)

Sep 14, 2026

Published

Sep 16, 2026

Ingested by INSIDER

Nov 5, 02:16 UTC

Last re-read

Nov 5, 02:16 UTC

Extracted facts

Filer

Mazzacco Catherine

Role

Director

Transaction

Grant or awardAs filed: “A”

Asset

Krystal Biotech, Inc. — Stock Option (Right to Buy)

Ticker

KRYS

Shares

1,187

Price per share

$0

Execution date (reported)

Sep 14, 2026

Owned after transaction

1,187 shares

Days from execution to publication

2

What this establishes

Mazzacco Catherine filed this Form 4 reporting a grant or award of KRYS on Sep 14, 2026. It became public on Sep 16, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

Extraction

Method

Form 4 XML

Confidence

1.00

Director

Mazzacco Catherinecik:0001967722

Issuer

Krystal Biotech, Inc.cik:0001711279

Revision history · 0

No field has changed since this record was first ingested.